Source comparison
Real Peptides Epithalon vs Competitors Quality: Full Comparison
Before selecting an Epithalon supplier, understanding the specific markers that separate research-grade peptides from commercial-grade alternatives is essential. This table breaks down the critical quality factors across synthesis, verification, and handling.
This comparison does not assign a generated winner or score.
- Before selecting an Epithalon supplier, understanding the specific markers that separate research-grade peptides from commercial-grade alternatives is essential. This table breaks down the critical quality factors across synthesis, verification, and handling.
- Synthesis Method
- Fmoc solid-phase with in-process MS verification
- Liquid-phase batch synthesis, endpoint testing only
- Sequential verification prevents error propagation; liquid-phase allows coupling failures to compound
- Real Peptides' method eliminates 90% of structural errors that pass endpoint purity tests
- Purity Verification
- Dual HPLC + MS/MS sequence confirmation
- HPLC only, often in-house labs
- MS/MS detects incorrect sequencing that HPLC misses
- Sequence errors render peptides biologically inactive despite high purity percentages
- Endotoxin Testing
- LAL assay, <0.5 EU/mg guaranteed
- Rarely tested; levels often exceed 5 EU/mg
- Endotoxins trigger inflammation that opposes Epithalon's anti-senescence mechanism
- High endotoxin levels can negate intended research outcomes entirely
- Storage During Shipping
- Cold packs + insulated mailers, 2–8°C maintained
- Room temperature shipping common
- Epithalon degrades 8–12% within 48 hours at ambient temperature
- Peptide activity lost in transit cannot be recovered through refrigeration
- Reconstitution Guidance
- Detailed protocol with shear-stress warnings
- Generic or absent
- Mechanical shear fragments 15–20% of peptides during improper reconstitution
- Most 'failed' Epithalon studies trace back to handling errors, not peptide quality
- Batch Consistency
- <2% variation across batches (MS verified)
- 4–7% variation typical
- Consistent results require consistent peptide structure batch-to-batch
- Variable batches make dose-response studies unreliable